ARCUTIS BIOTHERAPEUTICS, INC.: cash_and_restricted_cash
| Value | {"amount": 89323000, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "currency": "USD"} |
|---|---|
| Period | (as of 2023-12-31) |
| Status | current |
| Entity | ARCUTIS BIOTHERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:04:57.915266+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/daa0e21b-cad1-4a40-9699-41f866527a92
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001787306-24-000031Retrieved: 2026-08-19T18:04:57.915266+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001787306/cash-and-restricted-cash/2023-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/daa0e21b-cad1-4a40-9699-41f866527a92
History
- no predecessors — first report